Ang II was intravenously administered to Dkk3−/−Apoe−/− and Dkk3+/+Apoe−/− mice at 1,000 ng/(kg × min) for 4 weeks to establish the AAA model. The gene discussed is AGT; the disease is triple-A syndrome.